MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis
MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen’s University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD).
MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
MultiOmic Health has closed a £5 million seed extension round to build its precision therapeutics discovery platform for metabolic syndrome.
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease
Honoured to be selected as winners of BIA’s Innovation Showcase in the first ever TechBioUK conference
MultiOmic is proud to announce winning first place in the pitch competition at BIA’s TechBio UK Conference 2022